TrademarkDir
TEDOPI
LIVE

Serial Number

97092394

Owner

OSE IMMUNOTHERAPEUTICS

Attorney

Patrick J. Jennings

Filing Date

Oct 26, 2021

Add to watchlist:

No watchlists yet
+ Create New Watchlist
View on USPTO

TEDOPI Trademark

Serial Number: 97092394 • Registration: 7870681

TEDOPI is a trademark filed by OSE IMMUNOTHERAPEUTICS on October 26, 2021. The trademark is classified under Class 5 (Pharmaceuticals). The application is currently registered and active.

Owner Contact Info

OSE IMMUNOTHERAPEUTICS (16 trademarks)

22 Boulevard Benoni Gouillin
44200 Nantes , FR

Entity Type: 33

Trademark Details

Filing Date

October 26, 2021

Registration Date

July 22, 2025

First Use in Commerce

May 24, 2024

Published for Opposition

September 6, 2022

Goods & Services

Pharmaceutical products for cancer treatment, oncology and immunotherapy; Sanitary preparations for medical use; Pharmaceutical products for use in human medicine for cancer treatment, oncology and immunotherapy; Chemical preparations for pharmaceutical or medical purposes, namely, for cancer treatment, oncology and immunotherapy; Vaccines; Medicated serums for cancer treatment, oncology and immunotherapy; Chemical reagents for medical purposes

Filing History

NOTICE OF REGISTRATION CONFIRMATION EMAILED
Jul 22, 2025 NRCC
REGISTERED-PRINCIPAL REGISTER
Jul 22, 2025 R.PR
NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Jul 16, 2025 SUNA
ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Jul 1, 2025 CNPR
STATEMENT OF USE PROCESSING COMPLETE
Jun 27, 2025 SUPC
APPLICANT/CORRESPONDENCE CHANGES (NON-RESPONSIVE) ENTERED
Jun 27, 2025 CHAN
CASE ASSIGNED TO INTENT TO USE PARALEGAL
Jun 27, 2025 AITU
TEAS POST PUBLICATION AMENDMENT RECEIVED
Nov 25, 2024 EPPA
USE AMENDMENT FILED
Oct 28, 2024 IUAF
TEAS STATEMENT OF USE RECEIVED
Oct 28, 2024 EISU
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Apr 30, 2024 EXRA
SOU EXTENSION 3 GRANTED
Apr 29, 2024 EX3G
SOU EXTENSION 3 FILED
Apr 29, 2024 EXT3
SOU TEAS EXTENSION RECEIVED
Apr 29, 2024 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Oct 28, 2023 EXRA
SOU EXTENSION 2 GRANTED
Oct 26, 2023 EX2G
SOU EXTENSION 2 FILED
Oct 26, 2023 EXT2
SOU TEAS EXTENSION RECEIVED
Oct 26, 2023 EEXT
NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
May 2, 2023 EXRA
SOU EXTENSION 1 GRANTED
Apr 28, 2023 EX1G
SOU EXTENSION 1 FILED
Apr 28, 2023 EXT1
SOU TEAS EXTENSION RECEIVED
Apr 28, 2023 EEXT
NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Nov 1, 2022 NOAM
OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Sep 6, 2022 NPUB
PUBLISHED FOR OPPOSITION
Sep 6, 2022 PUBO
NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Aug 17, 2022 NONP
APPROVED FOR PUB - PRINCIPAL REGISTER
Aug 3, 2022 CNSA
ASSIGNED TO EXAMINER
Aug 3, 2022 DOCK
NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Nov 9, 2021 NWOS
NEW APPLICATION ENTERED
Oct 29, 2021 NWAP

Related Trademarks

More from this Owner

OSE IMMUNOTHERAPEUTICS

OSE IMMUNOTHERAPEUTICS

OSE IMMUNOTHERAPEUTICS

OSE IMMUNOTHERAPEUTICS

OSE IMMUNOTHERAPEUTICS

OSE IMMUNOTHERAPEUTICS

OSE-CYTOMASK

OSE-CYTOMASK

OSE-CYTOMASK

OSE-CYTOMASK

OSE-CYTOMASK

OSE-CYTOMASK